Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/14/2012EP2427465A1 Substituted spirocyclic amines useful as antidiabetic compounds
03/14/2012EP2427464A1 Pyrazolopyridines
03/14/2012EP2427463A1 Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
03/14/2012EP2427462A1 Pyrrolo [2, 3. b]pyridines which inhibit raf protein kinase
03/14/2012EP2427461A1 3-(ý1,2,3¨triazole-4-yl)-pyrroloý2,3-b¨pyridine derivates
03/14/2012EP2427460A1 Novel isoquinoline derivatives
03/14/2012EP2427459A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
03/14/2012EP2427458A1 Isoxazole-pyridazine derivatives
03/14/2012EP2427457A1 Isoxazole-pyridine derivatives as gaba modulators
03/14/2012EP2427456A1 Isoxazole-pyridine derivatives
03/14/2012EP2427455A1 Isoxazole-pyrazole derivatives
03/14/2012EP2427454A1 Phenoxymethyl heterocyclic compounds
03/14/2012EP2427453A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
03/14/2012EP2427452A1 P38 kinase inhibiting agents
03/14/2012EP2427451A1 Alpha helix mimetics and methods relating thereto
03/14/2012EP2427450A1 Gpr 119 modulators
03/14/2012EP2427449A1 Vinyl indazolyl compounds
03/14/2012EP2427448A1 Gpr 119 modulators
03/14/2012EP2427446A1 Inhibitors of sialidase or sialidase-like enzymes
03/14/2012EP2427445A1 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
03/14/2012EP2427444A1 Inhibitors of the renal outer medullary potassium channel
03/14/2012EP2427442A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP2427438A2 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427436A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
03/14/2012EP2427435A1 Substituted phenylureas and phenylamides as vanilloid receptor ligands
03/14/2012EP2427433A1 Solid forms of sulfonamides and amino acids
03/14/2012EP2427430A1 5-oxo-ete receptor antagonist compounds
03/14/2012EP2427429A1 Carboxamide compounds and their use as calpain inhibitors
03/14/2012EP2427417A1 Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
03/14/2012EP2427416A1 Substituted aromatic compounds and pharmaceutical uses thereof
03/14/2012EP2427415A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
03/14/2012EP2427243A1 Novel formulations of volatile anesthetics and methods of use for reducing inflammation
03/14/2012EP2427199A1 Methods of analyzing peptide mixtures
03/14/2012EP2427198A1 Use of an acylated octasaccharide as antithrombotic agent
03/14/2012EP2427197A2 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
03/14/2012EP2427196A1 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
03/14/2012EP2427195A2 Heterocyclic compounds and uses thereof
03/14/2012EP2427194A1 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/14/2012EP2427193A1 Use of pde7 inhibitors for the treatment of movement disorders
03/14/2012EP2427192A1 Use of osi-906 for treating adrenocortical carcinoma
03/14/2012EP2427191A1 Pesticidal compositions
03/14/2012EP2427190A1 8-aza tetracycline compounds
03/14/2012EP2427189A1 S1p3 receptor inhibitors for treating conditions of the eye
03/14/2012EP2427188A1 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
03/14/2012EP2427187A1 Antitumor combination including cabazitaxel and capecitabine
03/14/2012EP2427186A2 Dihydroorotate-dehydrogenasee inhibitors as virostatic compounds
03/14/2012EP2427185A1 Antitumor combination including ave8062 and sorafenib
03/14/2012EP2427184A1 Oral care method and kit
03/14/2012EP2427183A2 Therapeutic compounds
03/14/2012EP2427182A2 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
03/14/2012EP2427181A2 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester
03/14/2012EP2427180A1 Prevention and treatment of nosema disease in bees
03/14/2012EP2427178A2 Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
03/14/2012EP2427177A1 Composition for sustained drug delivery comprising geopolymeric binder
03/14/2012EP2427176A1 Polymer micelles containing sn-38 for the treatment of cancer
03/14/2012EP2427172A2 A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
03/14/2012EP2427167A1 Method and composition for restoration of age-related tissue loss in the face or selected areas of the body
03/14/2012EP2427160A1 Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
03/14/2012EP2427061A2 Gallium formulation for the treatment and prevention of infectious diseases
03/14/2012EP2427057A1 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/14/2012EP2427056A1 Methods of preventing ischemic injury using peripheral nociceptive stimulation
03/14/2012EP2427054A1 Solid formulations of prostacyclin analogs
03/14/2012EP2427053A1 Method of treating thrombocytopenia
03/14/2012EP2427052A1 Methods and compositions for treating ophthalmic conditions
03/14/2012EP2321319B1 Antiviral compounds
03/14/2012EP2284169B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
03/14/2012EP2240474B1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
03/14/2012EP2231590B1 Antitumoral compounds
03/14/2012EP2205750B1 Controlled activation of non-ltr retrotransposons in mammals
03/14/2012EP2202229B1 Novel preparation for external use
03/14/2012EP2200982B1 Piperidine derivatives as nk3 receptor antagonists
03/14/2012EP2185150B1 Use of tranilast and derivatives thereof for the therapy of neurological conditions
03/14/2012EP2152714B1 SPIROINDOLINONE DERIVATIVES AS MDM2-p53 INHIBITORS
03/14/2012EP2141155B1 Prophylactic and/or therapeutic agent for hyperlipidemia
03/14/2012EP2106401B1 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
03/14/2012EP2086975B1 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
03/14/2012EP2086538B1 Combination therapies for treating alzheimer's disease using dimebon and donepezil
03/14/2012EP2078018B1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
03/14/2012EP2065043B1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
03/14/2012EP2049112B1 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
03/14/2012EP2036896B1 Cyclic amine compound
03/14/2012EP2029600B1 Substituted pteridines substituted with a four-membered heterocycle
03/14/2012EP2013211B1 Purine derivatives for use as adenosin a2a receptor agonists
03/14/2012EP1971608B1 Spiroketals
03/14/2012EP1971603B1 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS
03/14/2012EP1968592B1 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds and a disaccharide for treating proliferative diseases
03/14/2012EP1948627B1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
03/14/2012EP1928872B1 Novel sulphonylpyrroles as inhibitors of hdac
03/14/2012EP1910287B1 Process for the preparation of crystalline perindopril
03/14/2012EP1868581B1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
03/14/2012EP1830835B1 Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pains and method for applying said agent
03/14/2012EP1828202B1 Rapamcyin analogues and the uses thereof in the treatment of neurological, proliferative and inflammatory disorders
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1636171B1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
03/14/2012EP1605926B1 Use of pinitol for treatment of liver diseases in mammals
03/14/2012EP1519743B1 Use of an interleukin 1 receptor antagonist alone or in combination with pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1474420B1 Quinazoline compounds
1 ... 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 ... 7860